Solubility of carbon dioxide in three lipid-based biocarriers
A. R. Sousa, Marilyn Calderone, Élisabeth Rodier, Jacques Fages, Catarina
M. M. Duarte

To cite this version:
A. R. Sousa, Marilyn Calderone, Élisabeth Rodier, Jacques Fages, Catarina M. M. Duarte. Solubility of carbon dioxide in three lipid-based biocarriers. to be soluble in carbon dioxide [18] . The critical condition in this case is the melting behaviour of the compound in the presence of carbon dioxide. In this work, the influence of carbon dioxide in the melting point of the three lipid matrices, Precirol ® ATO5, Compritol ® 888 ATO and Gelucire ® 43-01, was studied by a visual method for pressures up to 30 MPa. Equilibrium data of the solubility of carbon dioxide in the lipid mixtures was measured by a static analytical method for three different temperatures each, in a pressure range from 10 to 20 MPa.
Experimental
Materials
Precirol ® ATO5, Compritol ® 888 ATO and Gelucire ® 43-01 were kindly provided by Gattefossé. According to the supplier Precirol ® ATO5 is mainly composed of palmitic and stearic acids (C 16 and C 18 ), Compritol ® 888 ATO is mainly composed of behenic acid (C 22 ) and Gelucire ® 43-01 is a mixture of saturated fatty acids with carbon chains from C 12 to C 18 . Carbon dioxide (99.998 mol%) was supplied by Air Liquide and chloroform (99%) by Panreac Quimica SA.
Experimental procedures
In this study two different methods were used to investigate the incorporation of carbon dioxide in Precirol ® ATO5, Compritol ® 888 ATO and Gelucire ® 43-01. A visual method was applied to measure the variation of the compounds' melting points in the presence of carbon dioxide, and a static analytical method was applied to quantify the amount of carbon dioxide solubilized in the lipid matrices.
Melting point determination
The variation in the melting point of the lipidic mixtures was measured in a high-pressure apparatus, schematically presented in Fig. 1 , in a similar method to the one described by Fukné-Kokot et al. [19] . Briefly, a sample is placed inside a capillary tube, which by its turn is inserted in a high-pressure cell with sapphire windows, with an internal volume of approximately 4 cm 3 . The desired amount of carbon dioxide is pumped into the cell, with an accuracy of 0.05 MPa and then temperature is continuously increased until the last solid particle melts. Measurements were performed in a pressure range up to 30 MPa. Although accurate measurements are dependent on the observer, the direct observation of the phase equilibrium and the small amounts of sample required are clear advantages of this method. But even to confirm the accuracy some points were randomly repeated and the maximum deviation obtained was 0.2 • C.
Solubility measurements
The amount of carbon dioxide incorporated in the lipid matrices was measured by for three different temperatures each, in a pressure range from 10 to 20 MPa. The measurements were performed using the high-pressure apparatus shown in Fig. 2 , using a similar method to the one described by Matias et al. [20] . A stainless steel cell, with sapphire windows and an internal volume of approximately 60 cm 3 , is loaded with about 10 g of the lipid carrier and placed in a thermostated air bath heated by means of a controller that maintained temperature within ±0.1 • C. The system is then pressurized with fresh carbon dioxide until the desired pressure is brought into the cell, with an error of ±0.007 MPa and the mixture is magnetically stirred. At the fixed temperature, a typical equilibration time is 1 h. After 30 min of rest for equilibration, samples from the liquid phase are withdrawn through a high-pressure valve system, which is locally heated to avoid solidification of the samples upon pressure drops. The liquid samples were collected by quick depressurization and expansion into a small glass trap and the gas in them contained is further expanded into a calibrated volume at sub-atmospheric pressure. The amount of CO 2 in each sample is calculated from the increase of the resulting sub-atmospheric pressure at the working temperature: the number of CO 2 moles was determined from the measured gas volume using the second virial coefficient EOS. The sampling valve system is later flushed with chloroform to ensure all the product is collected and the amount of product is obtained by weighing after solvent evaporation in a vacuum chamber. Each data point obtained is the result of at least three measurements, with a maximum absolute relative deviation, AARD of 9%. where S exp and S calc are the experimental solubilities and the calculated average for n data points, respectively.
Analytical determination of the mixtures' composition
Lipid samples before and after melting were submitted to GC analysis to evaluate if the relative composition of the mixtures remained the same, or if fractionation occurred after melting and sampling. This method was standardized by the IUPAC and constitutes the basis of some European Regulations for determination of fatty acids. A separation capillary column Supelco SP-2380, 60 m × 0.32 mm with a film thickness of 0.2 m and split injection was used. Hydrogen was used as the gas carrier with a column inlet pressure of 100 kPa and a split of 120 mL/min. The samples were dissolved in heptane and 1 L was injected. The temperature program was 50 • C for 5 min, then at 4 • C/min to 250 • C hold for 25 min, with an initial temperature of the injector and the detector of 275 • C. The results were compared with a commercial standard solution Supelco FAME Mix C 14 -C 22 in the same conditions.
Results and discussion
The experimental data for the variation of the melting points of Precirol ® ATO5, Compritol ® 888 ATO and Gelucire ® 43-01 in the presence of carbon dioxide up to pressures of 30 MPa are presented in Fig. 3 This behaviour is explained by two competing phenomena: on one hand, the increase of the hydrostatic pressure increases the melting temperature of the compounds; on the other hand, if a gas is dissolved in a heavy substance the melting tempera- ture decreases, this prevails on the first part of the curve. This behaviour is a common one for fats and the melting point depression seems to be in the same order of magnitude from one fat to another. As an example, Elvassore et al. [21] measured the melting point of tristearin and the results are similar to ours. The rather scattered data obtained for the upper part of the melting curves, could be explained due to the fact that a visual method was employed, but most certainly the main reason is the polymorphic forms these compounds can assume, meaning that in some cases probably the predominant solid phase present was not the same. The solubility of carbon dioxide in Precirol ® ATO5 (C 16 and C 18 carbon dioxide in the heavy phase increases with pressure up to a maximum, and decreases with increasing temperature. This occurs because the density of the fluid decreases, and its vapour pressure increases with increasing temperature, thus making it less soluble in the molten mixture.
Comparing the data obtained with the structure of the different compounds, the shorter the carbon chains, the greater amount of carbon dioxide is incorporated. The fact that Precirol ® ATO5 and Gelucire ® 43-01 have some common composition also explains the similar variation (13 and 12 • C, respectively) in the melting in the presence of carbon dioxide.
The GC analysis showed no significant change in the relative compositions of the lipid mixtures (Fig. 7) . This is important because even if there is some solubility of the mixture components in the vapour phase, which probably will happen since the solubility in carbon dioxide of some of the pure components of the mixtures used in this study has already been reported [22] , there is no fractionation and the overall composition remains the same, meaning the properties of Precirol ® ATO5, Compritol ® 888 ATO and Gelucire ® 43-01 as biocarriers for active ingredients also remain the same.
Conclusions
In this work the incorporation of carbon dioxide in two lipid matrices was studied using two different methods. The measurement of the melting point variation of the compounds in the presence of carbon dioxide, for pressures up to 30 MPa, gave a qualitative idea of the amount incorporated; this amount was later quantified by results of the solubility experiments, carried out in pressures from 10 to 20 MPa, and for three different temperatures for each compound with a maximum relative deviation, AARD, of 9%.
For Precirol ® ATO5 it was found that the melting point could decrease up to 13 • C in the presence of carbon dioxide, and its solubility increases at constant temperature up to a maximum of approximately 0.4 g/g of Precirol ® ATO5. The melting point of Compritol ® 888 ATO decreases only 5 • C and it can incorporate carbon dioxide up to a maximum of 0.3 g/g of Compritol ® 888 ATO. Finally for Gelucire ® 43-01 the melting point depression obtained is 12 • C lower than at atmospheric pressure, and the solubility of carbon dioxide also increases with pressure up to approximately 0.5 g/g of Gelucire ® 43-01. The temperature effect is the opposite, for the same pressure, solubility decreases with increasing temperature. This is the main reason why it is so important to know the high-pressure equilibrium behaviour. If we can operate at lower temperatures and still have maximum incorporation of carbon dioxide in the lipid matrices, the supercritical particle formation process can later be designed more effectively in terms of yield and energy.
